These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 26662316

  • 1. MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1.
    Fan JY, Yang Y, Xie JY, Lu YL, Shi K, Huang YQ.
    Tumour Biol; 2016 May; 37(5):6855-60. PubMed ID: 26662316
    [Abstract] [Full Text] [Related]

  • 2. miR-495 mediates metabolic shift in glioma cells via targeting Glut1.
    Nie S, Li K, Huang Y, Hu Q, Gao X, Jie S.
    J Craniofac Surg; 2015 Mar; 26(2):e155-8. PubMed ID: 25759932
    [Abstract] [Full Text] [Related]

  • 3. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
    Wang Y, Yun Y, Wu B, Wen L, Wen M, Yang H, Zhao L, Liu W, Huang S, Wen N, Li Y.
    Oncotarget; 2016 Jul 26; 7(30):47985-47997. PubMed ID: 27351131
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3.
    Teng Y, Zhang Y, Qu K, Yang X, Fu J, Chen W, Li X.
    Oncotarget; 2015 Dec 01; 6(38):40799-814. PubMed ID: 26512921
    [Abstract] [Full Text] [Related]

  • 6. Ginsenoside 20(S)-Rg3 Inhibits the Warburg Effect Via Modulating DNMT3A/ MiR-532-3p/HK2 Pathway in Ovarian Cancer Cells.
    Zhou Y, Zheng X, Lu J, Chen W, Li X, Zhao L.
    Cell Physiol Biochem; 2018 Dec 01; 45(6):2548-2559. PubMed ID: 29558748
    [Abstract] [Full Text] [Related]

  • 7. Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells.
    Zheng X, Zhou Y, Chen W, Chen L, Lu J, He F, Li X, Zhao L.
    Cell Physiol Biochem; 2018 Dec 01; 51(3):1340-1353. PubMed ID: 30481782
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
    Zhao X, Lu C, Chu W, Zhang B, Zhen Q, Wang R, Zhang Y, Li Z, Lv B, Li H, Liu J.
    Tumour Biol; 2017 May 01; 39(5):1010428317706215. PubMed ID: 28488541
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
    Lu J, Wang L, Chen W, Wang Y, Zhen S, Chen H, Cheng J, Zhou Y, Li X, Zhao L.
    Arch Biochem Biophys; 2019 Jan 01; 661():1-9. PubMed ID: 30365936
    [Abstract] [Full Text] [Related]

  • 12. miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1.
    Santasusagna S, Moreno I, Navarro A, Muñoz C, Martinez F, Hernández R, Castellano JJ, Monzo M.
    Clin Transl Oncol; 2018 Sep 01; 20(9):1161-1167. PubMed ID: 29374351
    [Abstract] [Full Text] [Related]

  • 13. miR-383 inhibits ovarian cancer cell proliferation, invasion and aerobic glycolysis by targeting LDHA.
    Han RL, Wang FP, Zhang PA, Zhou XY, Li Y.
    Neoplasma; 2017 Sep 01; 64(2):244-252. PubMed ID: 28043152
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
    Guo LM, Pu Y, Han Z, Liu T, Li YX, Liu M, Li X, Tang H.
    FEBS J; 2009 Oct 01; 276(19):5537-46. PubMed ID: 19702828
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.
    Fu X, Cui Y, Yang S, Xu Y, Zhang Z.
    Tumour Biol; 2016 May 01; 37(5):6477-83. PubMed ID: 26631045
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-181b inhibits glycolysis in gastric cancer cells via targeting hexokinase 2 gene.
    Li LQ, Yang Y, Chen H, Zhang L, Pan D, Xie WJ.
    Cancer Biomark; 2016 Jun 07; 17(1):75-81. PubMed ID: 27314295
    [Abstract] [Full Text] [Related]

  • 17. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
    Chen WT, Yang YJ, Zhang ZD, An Q, Li N, Liu W, Yang B.
    J Ovarian Res; 2017 Jan 11; 10(1):1. PubMed ID: 28086946
    [Abstract] [Full Text] [Related]

  • 18. Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer.
    Wang J, Wang H, Liu A, Fang C, Hao J, Wang Z.
    Oncotarget; 2015 Aug 14; 6(23):19456-68. PubMed ID: 26062441
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
    Wu DD, Li XS, Meng XN, Yan J, Zong ZH.
    Tumour Biol; 2016 Aug 14; 37(8):10499-506. PubMed ID: 26850595
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
    Wang B, Sun F, Dong N, Sun Z, Diao Y, Zheng C, Sun J, Yang Y, Jiang D.
    Diagn Pathol; 2014 Nov 14; 9():211. PubMed ID: 25394492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.